european end-to-end CDMO company, pharma services
LinkedIn Share

Mabion Launches €500,000 Services Contest to Support Next-Gen Oncology Breakthroughs

Many lifesaving biopharmaceuticals are suffering from a slump in venture funding. Novel recombinant protein based therapeutics, but also biosimilars are needed to fill the gaps in unmet patient needs. At Mabion we understand how to advance promising biosimilars and novel biotherapeutics to the clinic and from there to patients. Unfortunately, many promising biopharmaceutical innovations spanning novel recombinant protein therapeutics to biosimilars are being held back in the current, limiting funding climate, depriving patients from access to advanced therapies. Yet the urgency to close gaps in unmet patient care has never been greater. That is why we are launching the “Unlocking the Future of Therapeutics” competition a unique opportunity to support and accelerate biologics development and scale up for an oncology-targeted therapeutic. We are offering €500,000 credit in development services to support an exceptional therapeutic project. This can be a novel therapeutic, but might also be a biosimilar drug which expands patients access to lifesaving care. We have partnered with respected academic experts focused on cancer research to select the most promising candidate.

Mabion, a leading biotech-focused CDMO offering end-to-end services, has announced the launch of a €500,000 oncology services contest at BIO International Convention 2025, aimed at accelerating the development of, recombinant protein-based cancer therapies. The contest will culminate at CPHI Worldwide in Frankfurt this October, spotlighting promising biotechs ready to scale their innovation.

“Despite unprecedented scientific advances, many oncology treatments still face hurdles at the funding stage,” said Julita Balcerek, Ph.D., COO at Mabion. “This contest is our invitation to innovators who just need the right partner. We’re offering more than a prize; we’re offering a path to impact”.

The initiative provides a simplified entry process via QR code at Mabion’s booth and a dedicated landing page. Selected entrants will be guided through pre-qualification, NDAs, and proposal shaping with Mabion’s business development team.

Rooted in a country that gave the world Marie Skłodowska-Curie and other scientific pioneers, Mabion proudly builds on Poland’s legacy of innovation. From groundbreaking research in radioactivity to modern-day biomanufacturing, the spirit of Polish science lives on in every partnership we forge. Łódź, once a global textile hub, is now a rising force in life sciences, and Mabion is helping shape that transformation.

An independent jury of experts will evaluate entries based on scientific merit, feasibility, and potential patient impact:

  • Prof. Tadeusz Pietrucha, Medical Biotechnology Department at Medical University of Łódź – Translational Oncology Expert
  • Prof. Gestur Vidarsson. PI and Head of Immunoglobulin Research at Sanquin Research at the Utrecht University and Chair of the Immunoglobulin Biotherapeutics group – Leading Expert in Immunoglobulin-based Biotherapeutics
  • Alicja Santos, Ph.D., CEO of Polonium Foundation – Biotech Talent Advocate
  • Julita Balcerek, Ph.D., COO of Mabion – CDMO Strategy Leader

The winner will receive a €500,000 credit toward Mabion’s integrated CDMO capabilities, including process and analytical development, upstream/downstream processing, and clinical supply manufacturing. Runner-up entries may also be invited into partnership discussions, reinforcing Mabion’s focus on long-term collaboration.

“Wherever you’re based, this is your chance to accelerate your breakthrough program with Mabion’s financial support and world class services,” Balcerek added. “Mabion is proud to help turn scientific ambition into clinical reality.”

The launch is supported by a multi-channel campaign featuring LinkedIn promotions, media outreach, email engagement, and in-booth activations at BIO International Convention and CPHI. Countdown content and giveaways will maintain visibility throughout the program.

More details can be found at Contest page.

Media Contact

Aranda Rahbarkouhi
 +44 7807 009 347
aranda@ramarketingpr.com

Share LinkedIn